|
1. Jauniaux E, Burton GJ. Pathophysiology of placenta accreta spectrum disorders: a review of current findings. Clin Obstet Gynecol. 2018; 61:743-54.doi: 10.1097/GRF.0000000000000392. 2. Hecht JL, Karumanchi SA, Shainker SA. Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders. Arch Gynecol Obstet. 2020; 301: 499-507. doi: 10.1007/s00404-020-05453-1. 3. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010; 63: 425-33. doi: 10.1111/j.1600-0897.2010.00836.x. 4. Orsi N, Tribe R. Cytokine networks and the regulation of uterine function in pregnancy and parturition. J Neuroendocrinol. 2008; 20: 462-9. doi: 10.1111/j.1365-2826.2008.01668.x. 5. Batebi A, Namavar-Jahromi B, Ali-Hassanzadeh M, Ahmadi M, Hosseini MS, Gharesi-Fard B. Evaluation of IL-17 and IL-35 serum levels in patients with preeclampsia. J Reprod Infertil. 2019; 20: 237-243. 6. Chu M, Tam LS, Zhu J, Jiao D, Cai Z, Dong J, et al. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice. Immunobiology. 2017; 222: 483-93. doi: 10.1016/j.imbio.2016.10.012. 7. Ge Y, Huang M, Wu Y, Dong N, Yao YM. Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells. J Cell Mol Med. 2020; 24: 2027-39. doi: 10.1111/jcmm.14902. 8. Boutet M-A, Nerviani A, Pitzalis C. IL-36, IL-37, and IL-38 cytokines in skin and joint inflammation: a comprehensive review of their therapeutic potential. Int J Mol Sci. 2019; 20: 1257. doi: 10.3390/ijms20061257. 9. Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016; 138: 984-1010. doi: 10.1016/j.jaci.2016.06.033. 10. Han Y, Mora J, Huard A, da Silva P, Wiechmann S, Putyrski M, et al. IL-38 ameliorates skin inflammation and limits IL-17 production from γδ T cells. Cell Rep. 2019; 27: 835-46. e5. doi: 10.1016/j.celrep.2019.03.082. 11. Southcombe J, Redman C, Sargent I, Granne I. Interleukin‐1 family cytokines and their regulatory proteins in normal pregnancy and pre‐eclampsia. Clin Exp Immunol. 2015; 181: 480-90. doi: 10.1111/cei.12608. 12. Shainker SA, Silver RM, Modest AM, Hacker MR, Hecht JL, Salahuddin S, et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol. 2020; 223: 433.e1-.e14. doi: 10.1016/j.ajog.2020.03.019. 13. Hecht JL, Karumanchi SA. Immune cell infiltrate at the utero-placental interface is altered in placenta accreta spectrum disorders. Arch Gynecol Obstet. 2020; 301: 499-507. doi: 10.1007/s00404-020-05453-1. 14. Gomez-Lopez N, StLouis D, Lehr MA, Sanchez-Rodriguez EN, Arenas-Hernandez M. Immune cells in term and preterm labor. Cell Mol Immunol. 2014; 11: 571-81. doi: 10.1038/cmi.2014.46. 15. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013; 94: 247-57. doi: 10.1189/jlb.1112603. 16. Raghupathy R. Cytokines as key players in the pathophysiology of preeclampsia. Med Princ Pract. 2013; 22: 8-19. doi: 10.1159/000354200. 17. Southcombe JH, Redman CW, Sargent IL, Granne I. Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia. Clin Exp Immunol. 2015;181: 480-90. doi: 10.1111/cei.12608. Epub 2015 Jun 29. 18. Clavel G, Thiolat A, Boissier MC. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint Bone Spine. 2013; 80: 449-53. doi: 10.1016/j.jbspin.2013.04.014. 19. Khamoushi T, Ahmadi M, Ali-Hassanzadeh M, Zare M, Hesampour F, Gharesi-Fard B, et al. Evaluation of Transforming Growth Factor-β1 and Interleukin-35 Serum Levels in Patients with Placenta Accreta. Lab Med. 2021;52: 245-9. doi: 10.1093/labmed/lmaa071. 20. Duzyj CM, Buhimschi IA, Laky CA, Cozzini G, Zhao G, Wehrum M, et al. Extravillous trophoblast invasion in placenta accreta is associated with differential local expression of angiogenic and growth factors: a cross-sectional study. BJOG. 2018; 125: 1441-8. doi: 10.1111/1471-0528.15176. 21. Schwede S, Alfer J, von Rango U. Differences in regulatory T-cell and dendritic cell pattern in decidual tissue of placenta accreta/increta cases. Placenta. 2014; 35: 378-85. doi: 10.1016/j.placenta.2014.03.004. 22. Takenaka S-i, Kaieda S, Kawayama T, Matsuoka M, Kaku Y, Kinoshita T, et al. IL-38: a new factor in rheumatoid arthritis. Biochem Biophys Rep. 2015; 4: 386-91. doi: 10.1016/j.bbrep.2015.10.015. 23. Rudloff I, Godsell J, Nold‐Petry CA, Harris J, Hoi A, Morand EF, et al. Brief report: interleukin‐38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus. Arthritis Rheumatol. 2015; 67: 3219-25. doi: 10.1002/art.39328. 24. Boutet MA, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, et al. Distinct expression of interleukin (IL)‐36α, β and γ, their antagonist IL‐36Ra and IL‐38 in psoriasis, rheumatoid arthritis and Crohn's disease. Clin Exp Immunol. 2016; 184: 159-73. doi: 10.1111/cei.12761. 25. Li J, Liu L, Rui W, Li X, Xuan D, Zheng S, et al. New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions. Dermatology. 2017; 233: 37-46. doi: 10.1159/000471798. 26. de Graaf DM, Jaeger M, van den Munckhof IC, Ter Horst R, Schraa K, Zwaag J, et al. Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects. Eur J Immunol. 2021;51: 662-71. doi: 10.1002/eji.201948390. 27. Yu Z, Liu J, Zhang R, Huang X, Sun T, Wu Y, et al. IL-37 and 38 signalling in gestational diabetes. J Reprod Immunol. 2017;124: 8-14. doi: 10.1016/j.jri.2017.09.011. 28. Mora J, Schlemmer A, Wittig I, Richter F, Putyrski M, Frank AC, et al. Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J Mol Cell Biol. 2016; 8: 426-38. doi: 10.1093/jmcb/mjw006. 29. Zhang J, Zhao R, Chen J, Jin J, Yu Y, Tian Y, et al. The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy. Sci Rep. 2017; 7: 2756. doi: 10.1038/s41598-017-03079-z.
|
